These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3839995)

  • 1. Directed biosynthesis of new saframycin derivatives with resting cells of Streptomyces lavendulae.
    Arai T; Yazawa K; Takahashi K; Maeda A; Mikami Y
    Antimicrob Agents Chemother; 1985 Jul; 28(1):5-11. PubMed ID: 3839995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulae.
    Mikami Y; Takahashi K; Yazawa K; Arai T; Namikoshi M; Iwasaki S; Okuda S
    J Biol Chem; 1985 Jan; 260(1):344-8. PubMed ID: 3880741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and structural elucidation of new saframycins Y3, Yd-1, Yd-2, Ad-1, Y2b and Y2b-d.
    Yazawa K; Takahashi K; Mikami Y; Arai T; Saito N; Kubo A
    J Antibiot (Tokyo); 1986 Dec; 39(12):1639-50. PubMed ID: 3818437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discovery and development of unknown potentialities of microorganisms with special reference to saframycin group antitumor antibiotics].
    Arai T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2617-24. PubMed ID: 6508318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of new semisynthetic saframycin derivatives.
    Kaneda S; Hour-Young C; Yazawa K; Takahashi K; Mikami Y; Arai T
    Jpn J Cancer Res; 1986 Oct; 77(10):1043-9. PubMed ID: 3096920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production of saframycin A and isolation of saframycin S.
    Arai T; Takahashi K; Ishiguro K; Yazawa K
    J Antibiot (Tokyo); 1980 Sep; 33(9):951-60. PubMed ID: 7440416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and conformation of saframycin R determined by high field 1H and 13C NMR and its interactions with DNA in solution.
    Lown JW; Hanstock CC; Joshua AV; Arai T; Takahashi K
    J Antibiot (Tokyo); 1983 Sep; 36(9):1184-94. PubMed ID: 6630077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalysis of Extracellular Deamination by a FAD-Linked Oxidoreductase after Prodrug Maturation in the Biosynthesis of Saframycin A.
    Song LQ; Zhang YY; Pu JY; Tang MC; Peng C; Tang GL
    Angew Chem Int Ed Engl; 2017 Jul; 56(31):9116-9120. PubMed ID: 28561936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of saframycin A, a heterocyclic quinone anti-tumor antibiotic to DNA as revealed by the use of the antibiotic labeled with [14C]tyrosine or [14C]cyanide.
    Ishiguro K; Takahashi K; Yazawa K; Sakiyama S; Arai T
    J Biol Chem; 1981 Mar; 256(5):2162-7. PubMed ID: 7193208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of a novel antitumor antibiotic, saframycin A.
    Arai T; Takahashi K; Nakahara S; Kubo A
    Experientia; 1980 Sep; 36(9):1025-7. PubMed ID: 7418832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new saframycin, saframycin R.
    Asaoka T; Yazawa K; Mikami Y; Arai T; Takahashi K
    J Antibiot (Tokyo); 1982 Dec; 35(12):1708-10. PubMed ID: 7166536
    [No Abstract]   [Full Text] [Related]  

  • 12. Mode of action of saframycin antitumor antibiotics: sequence selectivities in the covalent binding of saframycins A and S to deoxyribonucleic acid.
    Rao KE; Lown JW
    Chem Res Toxicol; 1990; 3(3):262-7. PubMed ID: 2131839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of saframycins. X. Transformation of (-)-saframycin A to (-)-saframycin Mx type compound with the structure proposed for saframycin E.
    Saito N; Harada S; Nishida M; Inouye I; Kubo A
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):777-82. PubMed ID: 7553964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of saframycins.
    Kishi K; Yazawa K; Takahashi K; Mikami Y; Arai T
    J Antibiot (Tokyo); 1984 Aug; 37(8):847-52. PubMed ID: 6480503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemo-enzymatic Total Syntheses of Jorunnamycin A, Saframycin A, and N-Fmoc Saframycin Y3.
    Tanifuji R; Koketsu K; Takakura M; Asano R; Minami A; Oikawa H; Oguri H
    J Am Chem Soc; 2018 Aug; 140(34):10705-10709. PubMed ID: 30113836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564.
    Mao Y; Varoglu M; Sherman DH
    Chem Biol; 1999 Apr; 6(4):251-63. PubMed ID: 10099135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural studies on minor components of saframycin group antibiotics saframycins F, G and H.
    Mikami Y; Takahashi K; Yazawa K; Hour-Young C; Arai T; Saito N; Kubo A
    J Antibiot (Tokyo); 1988 Jun; 41(6):734-40. PubMed ID: 3403367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of binding and single-strand scission of deoxyribonucleic acid by the antitumor antibiotics saframycins A and C.
    Lown JW; Joshua AV; Lee JS
    Biochemistry; 1982 Feb; 21(3):419-28. PubMed ID: 7066293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and biosynthesis of FD-594; a new antitumor antibiotic.
    Kondo K; Eguchi T; Kakinuma K; Mizoue K; Qiao YF
    J Antibiot (Tokyo); 1998 Mar; 51(3):288-95. PubMed ID: 9589064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two multifunctional peptide synthetases and an O-methyltransferase are involved in the biosynthesis of the DNA-binding antibiotic and antitumour agent saframycin Mx1 from Myxococcus xanthus.
    Pospiech A; Bietenhader J; Schupp T
    Microbiology (Reading); 1996 Apr; 142 ( Pt 4)():741-746. PubMed ID: 8936303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.